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Prior contralateral amputation predicts worse
outcomes for lower extremity bypasses performed
in the intact limb
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David H. Stone, MD,c YouFu Li, MD, MPH,b Jack L. Cronenwett, MD,c and Andres Schanzer, MD,a
for the Vascular Study Group of New England, Worcester, Mass; and Lebanon, NH
Introduction: To date, history of a contralateral amputation as a potential predictor of outcomes after lower extremity
bypass (LEB) for critical limb ischemia (CLI) has not been studied. We sought to determine if a prior contralateral lower
extremity amputation predicts worse outcomes in patients undergoing LEB in the remaining intact limb.
Methods: A retrospective analysis of all patients undergoing infrainguinal LEB for CLI between 2003 and 2010 within
hospitals comprising the Vascular Study Group of New England was performed. Patients were stratified according to
whether or not they had previously undergone a contralateral major or minor amputation before LEB. Primary end
points included major amputation and graft occlusion at 1 year postoperatively. Secondary end points included
in-hospital major adverse events, discharge status, and mortality at 1 year.
Results:Of 2636 LEB procedures, 228 (8.6%) were performed in the setting of a prior contralateral amputation. Patients
with a prior amputation compared to those without were younger (66.5 vs 68.7; P .034), more like to have congestive
heart failure (CHF; 25% vs 16%; P  .002), hypertension (94% vs 85%; P  .015), renal insufficiency (26% vs 14%; P 
.0002), and hemodialysis-dependent renal failure (14% vs 6%; P .0002). They were also more likely to be nursing home
residents (8.0% vs 3.6%; P  .036), less likely to ambulate without assistance (41% vs 80%; P < .0002), and more likely
to have had a prior ipsilateral bypass (20% vs 12%; P  .0005). These patients experience increased in-hospital major
adverse events, including myocardial infarction (MI; 8.9% vs 4.2%; P  .002), CHF (6.1% vs 3.4%; P  .044),
deterioration in renal function (9.0% vs 4.7%; P  .006), and respiratory complications (4.2% vs 2.3%; P  .034). They
were less likely to be discharged home (52% vs 72%; P< .0001) and less likely to be ambulatory on discharge (25% vs 55%;
P < .0001). Although patients with a prior contralateral amputation experienced increased rates of graft occlusion (38%
vs 17%; P < .0001) and major amputation (16% vs 7%; P < .0001) at 1 year, there was not a significant difference in
mortality (16% vs 10%; P  .160). On multivariable analysis, prior contralateral amputation was an independent
predictor of both major amputation (odds ratio, 1.73; confidence interval, 1.06-2.83; P  .027) and graft occlusion
(odds ratio, 1.93; confidence interval, 1.39-2.68; P < .0001) at 1 year.
Conclusions: Patients with prior contralateral amputations who present with CLI in the intact limb represent a high-risk
population, even among patients with advanced peripheral arterial disease. When considering LEB in this setting, both
physicians and patients should expect increased rates of perioperative adverse events, increased rates of 1-year graft
occlusion, and decreased rates of limb salvage, when compared with patients who have not undergone a contralateral
amputation. (J Vasc Surg 2012;56:353-60.)
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peripheral arterial disease and it is associated with high rates
of concomitant comorbidities which influence the treat-
ment paradigms of this patient population. The primary
goal in patients with CLI is limb salvage, particularly in
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doi:10.1016/j.jvs.2012.01.041hose who have previously undergone a prior contralateral
mputation, in order to avoid the complications and de-
reased quality of life associated with decreased mobility.
espite advances in endovascular therapies, infrainguinal
ower extremity bypass (LEB) remains the gold standard
or treatment of CLI.1,2 However, LEB continues to have
on-negligible rates of both early and late failures as well as
ignificant perioperative morbidity and mortality.3,4 Addi-
ionally, numerous factors have been associated with LEB
ypass failures, including poor conduit, renal dysfunction,
rior failed endovascular intervention, female gender, and
onwhite race.5-9
No study to date has evaluated the impact of a prior
ontralateral amputation on subsequent LEB outcomes in
he intact limb. These patients seem to represent a more
orbid subgroup of patients with CLI who may be at
igher risk for perioperative adverse events. Additionally,
hese patients have limited mobility and overall diminished
unction compared with patients with an intact contralat-
353
L
t
a
m
p
p
l
a
S
e
f
c
p
g
C
t
g
a
m
f
a
A
w
R
(
p
t
t
t
h
r
P
h
t
t
m
1
c
i
b
.
P
n
i
o
q
c
P
t
JOURNAL OF VASCULAR SURGERY
August 2012354 Baril et aleral limb, which may place them at increased risk of longer-
term complications, including higher rates of graft occlu-
sion, ipsilateral amputation, and mortality. The purpose of
this study was to use data from the prospectively collected
Vascular Study Group of New England (VSGNE) database
to better characterize the subgroup of patients with CLI
who have undergone a prior contralateral amputation and
to determine if a prior contralateral lower extremity ampu-
tation predicts worse outcomes in patients undergoing
LEB in the remaining intact limb.
METHODS
Study design and database. This study was a retro-
spective analysis of patients undergoing LEB for CLI be-
tween January 1, 2003 and December 31, 2009 at 12
centers that participate in the VSGNE. The VSGNE is a
regional cooperative quality improvement initiative devel-
oped by community and academic centers in New England
in 2002 to evaluate regional outcomes in vascular surgery.
Details regarding this registry have been previously pub-
lished and are available at http://www.vsgne.org as well.10
All data are self-reported and sent to a central data reposi-
tory where they are aggregated and reviewed.
Data are collected at the time of the initial operation,
including preoperative, intraoperative, and postoperative
information. Follow-up data are then subsequently col-
lected at 1 year. One-year data collected include ambula-
tion status, symptom status, graft patency, ankle-brachial
index, need for graft revisions, and amputations.
Definitions. Patient information for 100 clinical and
demographic variables was collected (complete list available at
http://www.vsgne.org). Specific comorbidities examined in-
cluded coronary artery disease (CAD; prior myocardial infarc-
tion [MI]; or angina), chronic obstructive pulmonary disease
(medication-dependent, or home oxygen-dependent), con-
gestive heart failure (CHF; by history), diabetes mellitus (in-
sulin dependent diabetes mellitus [IDDM], or noninsulin
dependent diabetes mellitus [NIDDM], controlled by oral
medication or diet), hypertension (history of hypertension or
blood pressure140/90 mmHg on the preoperative evalu-
ation), and history of tobacco use (never, 1 year prior, or
current). Renal disease was classified as normal (serum creati-
nine 1.8 mg/dL), renal insufficiency (serum creatinine
1.8 mg/dL), or dialysis-dependent.
Relevant surgical history is also obtained at the time
of initial operation, including prior ipsilateral and con-
tralateral endovascular and open revascularizations. Fur-
thermore, prior ipsilateral and contralateral minor and
major amputations are recorded. Preoperative functional
status is also obtained and classified as ambulatory, am-
bulatory with assistance, wheelchair-reliant, and bedrid-
den.
Immediate postoperative data relating to major in-
hospital adverse events, including the occurrence of MI,
dysrhythmia, CHF, change in renal function, respiratory
complications, and stroke, are recorded. Discharge ambu-
lation status and disposition (home, rehabilitation unit,
nursing home, or skilled nursing facility) are also obtained. oong-term follow-up data include vital status, graft pa-
ency, and amputation status. Graft patency is determined
t 1 year by the practitioners via one of the following
ethods: Doppler examination, palpable graft pulse, pal-
able distal pulse, ankle-brachial index increase0.15 from
reoperative value, or duplex scan. Postoperative surveil-
ance is not standardized across institutions.
Study end points. The primary end points were major
mputation and graft occlusion at 1 year postoperatively.
econdary end points included in-hospital major adverse
vents (specifically MI, dysrhythmia, CHF, change in renal
unction, and respiratory complications), as well as dis-
harge status and mortality at 1 year.
Statistical analysis. Baseline characteristics were com-
ared between groups using Pearson 2 analysis for cate-
orical variables and the t-test for continuous variables.
ox proportional hazards models were constructed to de-
ermine independent predictors of major amputation and
raft occlusion at 1 year. Variables with P .2 in univariate
nalysis were included in covariates selection by step-wise
ultivariate analysis. Covariates with P  .05 were en-
orced in the final model. The Kaplan-Meier life table
nalyses were used to calculate all time-to-event end points.
ll software analyses were performed using SAS 9.1 soft-
are (SAS Institute, Cary, NC).
ESULTS
Cohort characteristics. Two hundred twenty-eight
8.6%) of 2636 LEBs were performed in the setting of a
rior contralateral amputation, including 107 major ampu-
ations and 121 minor amputations. When compared to
hose patients who had no history of a contralateral ampu-
ation, patients in the study cohort were younger and had
igher incidences of CAD, CHF, IDDM, hypertension,
enal insufficiency, and need for hemodialysis (Table I).
atients with no history of a contralateral amputation had a
igher incidence of NIDDM.
Preoperative surgical history and functional status of
he patients in the groups were significantly different. Pa-
ients with a history of a contralateral amputation were
ore likely to have had a prior ipsilateral bypass (19.6% vs
1.5%; P .0005) on their index limb. Patients with a prior
ontralateral amputation were also more likely to be nurs-
ng home residents (8.0% vs 3.6%; P  .002), less likely to
e ambulatory without any assistance (41.1% vs 80.2%; P
0001), and more often wheelchair-reliant (22.4% vs 3.1%;
 .001). There were few patients in each group who were
ursing home residents and who were nonambulatory,
ncluding 69 in the group without a prior amputation and
nly 16 in the amputation group.
Tissue loss as an indication for bypass was more fre-
uent in patients with prior major and minor amputations
ompared to those without (75.7% and 77.0% vs 42.4%;
 .0001). There were no significant differences in the
ype of conduit used amongst the different groups.
Specifically, there were no differences in the frequenciesf the use of single segment greater saphenous vein, alter-
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Volume 56, Number 2 Baril et al 355native vein (arm vein or small saphenous vein), spliced vein,
cryopreserved vein, or prosthetic conduit.
Bypass target vessels differed among the groups.
Above-knee popliteal artery was a more common target in
patients without a prior contralateral amputation (26.7% vs
17.6%; P  .001). Tibial targets were more common for
patients with prior contralateral amputations (50.9% vs
37.5%; P .001). There was no significant difference in the
proportion of patients without and with prior contralateral
amputations who underwent LEB with below-knee popli-
teal targets (35.9% vs 31.4%; P  .011).
Perioperative major adverse events and discharge
status. Patients with a prior contralateral amputation
experienced an increased rate of in-hospital major ad-
verse events following LEB compared to those with an
intact contralateral limb (19.0% vs 12.5%; P  .044).
Specifically, these patients had higher rates of postoper-
ative MIs (8.9% vs 4.2%; P  .002), CHF exacerbations
(6.1% vs 3.4%; P  .044), deterioration in renal function
(9.0% vs 4.7%; P  .006), and respiratory complications
(4.2% vs 2.3%; P  .034; Table II).
Patients with a prior contralateral amputation were less
likely to be discharged home (51.9% vs 72.2%; P  .0001)
and less likely to be ambulatory on discharge (25.1% vs
55.3%; P .0001) when compared to those without a prior
contralateral amputation. With respect to these numbers, it
should be noted that patients with a prior contralateral
amputation were more likely not to live at home indepen-
dently preoperatively and were less likely to ambulate inde-
Table I. Patient demographics and procedural details
Variable
No prior
contralateral
amputation
(n  2408)
Prior
contralateral
amputation
(n  228) P value
Age, mean 68.7 66.5 .007
Male gender % 70.0 70.1 .984
CAD % 36.5 46.3 .005
CHF % 16.3 24.9 .001
COPD % 29.5 30.4 .794
Diabetes %
NIDDM 52.4 31.8 .0001
IDDM 47.6 68.2 .0001
Hypertension % 85.4 94.4 .001
Renal insufficiency % 13.8 26.0 .0001
Hemodialysis % 6.0 13.6 .0001
Preoperative nursing home
resident %
3.6 8.0 .002
Independent ambulation % 80.2 41.1 .0001
Prior ipsilateral bypass % 11.5 19.6 .0005
Tobacco use % 55.0 51.4 .306
Beta-blocker usage % 80.9 87.8 .013
Aspirin usage % 72.4 69.6 .389
Statin usage % 62.2 55.1 .040
Prosthetic conduit % 25.6 21.3 .441
Tibial target 37.5 50.9 .001
CAD, Coronary artery disease; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; IDDM, insulin dependent diabetes
mellitus; NIDDM, noninsulin dependent diabetes mellitus.pendently preoperatively. oStatus at 1 year. Patients with a prior contralateral
mputation experienced increased rates of graft occlusion
37.5% vs 16.7%; P .0001) andmajor amputation (15.9%
s 6.7%; P  .0001) at 1 year (Figs 1 and 2) compared to
hose without. However, there was no statistically signifi-
ant difference in mortality (15.8% vs 10.4%; P  .160)
etween the two groups at 1 year (Fig 3). On multivariable
nalysis, after controlling for potential confounding vari-
bles, prior contralateral amputation was an independent
redictor of both graft occlusion (odds ratio [OR], 1.93;
onfidence interval [CI], 1.39-2.68; P .0001; Table III)
ndmajor amputation (OR, 1.73; CI, 1.06-2.83; P .027;
able IV) at 1 year. These potential factors, which were
ased on the univariate screen, included age, gender, race,
istory of CHF, hypertension, renal insufficiency, preoper-
tive beta-blocker usage, prior ipsilateral bypass, prosthetic
onduit, and tibial target.
At 1 year, patients with a prior contralateral amputation
ere less likely to be ambulatory without assistance (51.1%
s 82.6%; P  .0001) and more likely to be wheelchair-
ependent (24.5% vs 6.1%; P  .0001).
Subgroup analysis stratified by major and minor
mputations. After stratifying patients by whether or not
hey had undergone a prior contralateral major amputation
n 107) or minor amputation (n 121), both subgroups
emonstrated similar findings to the combined prior con-
ralateral amputation cohort. Patients with either a prior
ajor or minor contralateral amputation had increased
ates of any in-hospital major adverse event when compared
ith patients with an intact contralateral limb, although
hese differences did not reach statistical significance. Spe-
ifically, however, patients with either prior major or minor
mputations did have significantly higher rates of both MI
nd change in renal function compared with patients with
n intact contralateral limb (Table II). Fewer patients with
ither a prior contralateral major or minor amputation
mbulated independently at discharge compared with pa-
ients with an intact contralateral limb (10.6%; P  .0001
nd 40.7%; P .006 vs 55.3%). Additionally, fewer patients
ith either a prior contralateral major or minor amputation
ere discharged home compared with patients with an
ntact contralateral limb (49.0%; P .0001 and 57.8%; P
003 vs 72.2%).
Rates of graft occlusion at 1 year for patients with either
prior contralateral major or minor amputation were sig-
ificantly higher than for patients with an intact contralat-
ral limb (49.5%; P  .0001 and 30.8%; P  .0001 vs
6.7%). Additionally, rates of major amputation at 1 year in
he limb undergoing LEB were significantly higher for
atients with either a prior contralateral major or minor
mputation compared to those with an intact contralateral
imb (17.5%; P  .0005 and 15.3%; P  .0005 vs 6.7%).
On multivariate analysis, prior contralateral minor am-
utation nearly achieved but did not reach significance as an
ndependent predictor of graft occlusion (OR, 1.59; CI,
.98-2.58; P  .06); however, prior major contralateral
mputation was a significant independent predictor of graft
cclusion (OR, 2.26; CI, 1.50-3.40; P  .0001). When
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August 2012356 Baril et alexamined individually, prior contralateral major and minor
amputation did not reach statistical significance as indepen-
dent predictors of major amputation (OR, 1.99; CI, 0.99-
3.98; P  .05 and OR, 1.57; CI, 0.85-2.91; P  .15,
respectively).
DISCUSSION
The treatment of CLI, either through conventional
bypass or endovascular techniques, is aimed at limb salvage;
however, a significant number of patients progress to re-
quire minor and major amputations despite intervention.
Additionally, patients may initially present with advanced
gangrene necessitating primary amputation. A certain sub-
set of these patients will later present with CLI in the
remaining intact limb. This study demonstrates that this
group of patients merits special consideration. These pa-
tients have higher comorbidity rates and suffer from higher
rates of in-hospital major adverse events following LEB
compared to those with an intact contralateral limb. Fur-
thermore, fewer patients with a prior contralateral amputa-
tion are discharged to home and fewer ambulate indepen-
dently following LEB. At 1 year, this patient population
Fig 1. Freedom
Table II. Perioperative major adverse events
Adverse event
No prior
contralateral
amputation
Prior
contralateral
amputation P
MI % 4.2 8.9 .
Dysrhythmia % 4.4 6.5 .
CHF % 3.4 6.1 .
Change in renal function % 4.7 9.0 .
Respiratory % 2.3 4.2 .
Any in-hospital major
adverse event % 12.5 19.0 .
CHF, Congestive heart failure; MI, myocardial infarction.continues to experience worse outcomes when compared uo those with an intact contralateral limb, as they endure
igher rates of both graft occlusion and amputation.
Despite decreasing rates of lower extremity amputa-
ions in recent years, along with increasing usage of endo-
ascular techniques to treat CLI,11,12 patients with a con-
ralateral amputation continue to make up a significant
ortion of patients presenting with CLI in the intact limb.
atients with a prior contralateral amputation accounted
or nearly 10% of all patients undergoing surgical bypass in
he VSGNE registry. Previously, it has been shown that up
o 30% of patients undergoing infrainguinal bypass will
ubsequently require contralateral intervention, including
mputation.13 Furthermore, up to 25% of patients with a
rior amputation will require a contralateral amputation or
eamputation either for progressive limb ischemia or revi-
ion due to wound complications.14
Given the relatively common frequency of patients
resenting with CLI and a prior contralateral amputation,
ractitioners are often faced with determining the optimal
reatment modality for such patients. In this setting, limb
alvage is particularly important to maintaining indepen-
ence. Even in patients with a prior amputation who do not
graft occlusion.
Prior
contralateral
major amputation P value
Prior
contralateral
minor amputation P value
8.4 .040 9.7 .002
5.6 .565 5.4 .156
6.5 .085 3.2 .925
9.5 .024 9.0 .006
3.7 .528 4.2 .034
20.8 .191 18.3 .102value
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044se a prosthesis for ambulation, functional limb salvage in
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Volume 56, Number 2 Baril et al 357the intact limb is key as this allows for pivot support during
transfers or the ability to maintain ambulation with an
assistance device. Unfortunately, previous work has dem-
onstrated that patients with bilateral lower extremity am-
putations are most commonly wheelchair-dependent or
bedridden with 40% capable of ambulation.15
Patients with a prior contralateral amputation represent
a morbid subgroup of patients with CLI. The patients
reviewed in this study had significantly higher rates of
nearly all comorbidities when compared to those patients
with an intact contralateral limb. In particular, patients with
a contralateral amputation had higher rates of CAD,
IDDM, and renal insufficiency, all factors which have been
previously demonstrated to be associated with higher rates
of perioperative complications following LEB.3,16-18 Be-
Fig 2. Freedom fr
Fig 3yond the presence of higher rates of documented comor- jidities, patients with a prior contralateral amputation are,
verall, less functional than those with an intact contralat-
ral limb. Specifically, these patients had significantly lower
ates of preoperative independent ambulation and lower
ates of independent living. Based on a review of the
ational Surgical Quality Improvement Program database,
reoperative dependent functional status (requiring assis-
ance with activities of daily living) was associated with
igher rates of both perioperative mortality (6.1% vs 1.5%)
nd major complications (30% vs 14%) following LEB
hen compared to independent patients.18 Additionally,
he presence of renal dysfunction in a nonindependent
atient increased the odds of a major perioperative compli-
ation by sevenfold. Combining functional status along
ith the associated comorbidities, the 19% in-hospital ma-
ajor amputation.
vival.or adverse event rate for patients with a contralateral
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and confirms the concern that these patients are at partic-
ularly high risk for perioperative complications. In addition
to these tangible factors, there are a number of less well-
defined risks that patients with a prior contralateral ampu-
tation are prone to. Certainly, these patients are less ambu-
latory both preoperatively and postoperatively. This alone
places such patients at higher risk for complications, includ-
ing deep venous thrombosis (DVT) and pulmonary em-
bolus, atelectasis with associated pneumonias, and perhaps
increased use of urinary catheters and a subsequent in-
creased risk of urinary tract infections. Knowing that these
patients are at greater risk than patients with an intact limb
after LEB, it is prudent that even more attention is made to
preventative efforts for this population of patients, includ-
ing the aggressive use of DVT prophylaxis, incentive spi-
rometry, and maximal utilization of physical therapy ser-
vices.
Although numerous studies have evaluated predictors
of graft occlusion and amputation after LEB, no prior study
has examined the effect of a prior contralateral amputa-
tion.3-9 Based on the Kaplan-Meier life table analyses in this
study, the rates of both graft occlusion and amputation
were significantly higher for patients with prior contralat-
eral amputations. These effects were preserved for both
major and minor amputation subgroups, albeit with less
magnitude for patients with prior contralateral minor am-
putations. Furthermore, by multivariate analysis, the pres-
ence of a prior contralateral amputation was an indepen-
dent predictor of both graft occlusion and amputation at 1
year. Additionally, in subgroup analysis, major amputation
remained an independent predictor of graft occlusion.With
regard to additional factors predictive of graft occlusion,
Table III. Independent predictors of graft occlusion at 1
year
HR 95% CI P value
Nonindependent preoperative
ambulation 1.37 1.16-1.63 .003
Hemodialysis 1.66 1.09-2.54 .02
Prosthetic conduit 1.69 1.14-2.50 .008
Prior ipsilateral bypass 1.81 1.37-2.34 .0001
Prior contralateral amputation 1.93 1.39-2.68 .0001
Tibial target vessel 2.06 1.57-2.71 .0001
CI, Confidence interval; HR, hazard ratio.
Table IV. Independent predictors of amputation at 1
year
HR 95% CI P value
Age 50 1.03 1.01-1.05 .004
Prior contralateral amputation 1.73 1.06-2.83 .027
IDDM 2.08 1.38-3.13 .001
Nonwhite race 7.78 1.82-33.14 .006
CI, Confidence interval; HR, hazard ratio; IDDM, insulin dependent dia-
betes mellitus.this study demonstrated that in addition to a prior con- pralateral amputation, nonindependent ambulation, hemo-
ialysis, use of prosthetic conduit, prior ipsilateral bypass,
nd tibial target vessel were all associated with increased risk
f graft occlusion. Certainly, there is some overlap in these
arious factors when assessing the population of patients
ith prior amputations, but all were statistically significant
ased on the regression analysis. Similarly, additional pre-
ictors ofmajor amputation beyond prior contralateral ampu-
ation included younger patients, IDDM, and nonwhite race.
gain, there is overlap with these risk factors and the popula-
ion studied here, and furthermore, these factors have been
reviously demonstrated to be associated with worse out-
omes.8,9
The precise explanation as to why these patients have
orse outcomes with LEB is not entirely clear. There are
ertainly some patient factors that are not collected in
he VSGNE registry that might contribute. For example,
he presence of a hypercoagulable state may be an unmea-
ured confounder that places this population at increased
isk for graft occlusion and limb loss. However, hyperco-
gulability is not captured in the VSGNE registry and
herefore could not be included in the analysis. Additional
actors which may contribute to patients with a prior con-
ralateral amputation having worse outcomes include the
uality of conduit used and suboptimal outflow vessels.
he patients with prior amputations had significantly
igher rates of dialysis-dependence and IDDM, both
nown factors to be associated with diffuse calcific athero-
clerosis. These patients are commonly known to have
orse outflow compared with other patients with athero-
clerosis who lack these risk factors. Furthermore, anatom-
cally, patterns of disease are often symmetric and perhaps
atients who have had a prior contralateral amputation
ave advanced disease which places them at high risk for
ailure of interventions and limb loss in the intact limb as it
id in their contralateral limb. There aremultiple additional
actors that would be difficult to precisely assess their
ontribution to worse outcomes even if captured but are
orth consideration as to why these patients with prior
ontralateral amputations have worse outcomes. Included
n these are the limited mobility of such patients, their
ncreased risk of falls, along with their increased risk of
VT. It is quite plausible that all of these factors are
dditive and are responsible to some degree for worse
utcomes. Furthermore, the overall increased expenditure
f energy and difficulty performing simple activities of daily
iving likely further contribute to the worse outcomes.
dditionally, postoperative surveillance protocols may be
ore difficult for patients with limited mobility to adhere
o and it is possible that patients with a prior contralateral
mputation are not surveyed as frequently as those with an
ntact limb, leading to higher rates of graft failure and
ubsequent amputation.
The decision-tree regarding intervention for limb sal-
age in patients with CLI remains very challenging despite
he presence of risk models and the data from various
linical trials comparing endovascular and surgical ap-
roaches.2,19-21 Although it will be necessary to continue
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Volume 56, Number 2 Baril et al 359to individualize decisions regarding treatment options, it is
evident that patients with a prior contralateral amputation
have disadvantaged outcomes after LEB. Endovascular
therapy as a first-line treatment modality for such patients
may minimize the occurrence of the major adverse events
after LEB demonstrated here, particularly in light of the
outcomes at 1 year. However, this study did not address the
outcomes after endovascular approaches in the intact limb
in patients with a contralateral amputation and, as such, it is
impossible to make a direct comparison. Hypothetically,
given the less invasive nature of endovascular treatment, it
may be possible that patients with a contralateral amputa-
tion might fare better in the immediate perioperative time
period compared to LEB. At minimum, contralateral am-
putation should be considered to be an additional easily
identifiable preoperative risk factor associated with worse
perioperative and 1-year outcomes in the decision of how
to treat CLI in the intact limb. Interestingly, in this study,
although patients with a prior contralateral amputation
represented a more morbid patient population, there were
no significant differences in mortality at 1 year. Based on
the higher prevalence of comorbidities, the poorer func-
tional status, and the higher rates of perioperative events, it
seems that this lack of difference in survival is due to either
sample size, or perhaps, more likely, limited follow-up.
With this study as background, it is evident that future
studies will need to assess how the risk factor of a prior
contralateral amputation impacts outcomes after endovas-
cular revascularization techniques.
The primary limitation of this study was its retrospec-
tive nature. Although data in the VSGNE are collected
prospectively, the database is queried in a retrospective
fashion. Despite the breadth and detail of the information
which is obtained at the time of LEB, certain patient factors
are not captured. Specifically relevant to this study is the
lack of information regarding the presence of a docu-
mented hypercoagulable state, whichmay contribute to the
poor outcomes for this patient population. Similarly, not all
anatomic factors are recorded in detail such as quality of the
vein conduit or infrapopliteal runoff scores. Additionally,
the data are self-reported, which may lead to significant
observer bias. With regard to the history of a prior ampu-
tation, there is no differentiation recorded between trau-
matic amputations and those secondary to CLI. Certainly
this population may represent a somewhat different patient
population than patients who undergo an amputation for
CLI. Additionally, the date of the prior amputation was not
recorded and, therefore, time to LEB in the intact limb was
not incorporated in this analysis. Given this is a multi-
institutional and multi-surgeon database, postoperative
surveillance protocols may differ among institutions and
surgeons, which may contribute to disparate outcomes.
Surveillance schedules are not captured in the database.
Furthermore, as aforementioned, it is possible that patients
with a prior contralateral amputation are not as closely
followed postoperatively given their limited mobility and
difficulty attending outpatient visits. Despite these limita-
tions, this database collects data with very high accuracyhich has been previously validated10 and captures data
rom a diverse group of centers, including both academic
nd community hospitals.
ONCLUSIONS
Patients with prior contralateral amputations who pre-
ent with CLI in the intact limb represent a high-risk
opulation with increased comorbidity rates compared to
hose without. When considering LEB, both physicians
nd patients should expect increased rates of perioperative
dverse events, increased rates of 1-year graft occlusion,
nd decreased rates of limb salvage for such patients when
ompared with patients who do not have a contralateral
mputation. The presence of a prior contralateral amputa-
ion, along with other known predictors of LEB failure,
hould be factored into the decision tree when selecting
mong treatment modalities for lower extremity occlusive
isease.
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